Triple negative breast cancer (TNBC): Analysis of age and stage distribution and survival between African American and Caucasian women in a predominant low-income population.

Author:

Tano Sheeba V.1,Kavanaugh Mindie Michelle2,Peddi Prakash3,Mansour Richard P.1,Shi Runhua1,Burton Gary Von1

Affiliation:

1. LSU Health Sciences Center, Shreveport, LA;

2. LSUHSC-S, Shreveport, LA;

3. Louisiana State University Health Sciences Center, Shreveport, LA;

Abstract

e12586 Background: Triple negative breast cancers (TNBC) represent roughly 15% of all breast cancer and are associated with decreased overall survival. A higher incidence of TNBC has been seen in younger and African American patients. We investigated the effect of age and race relative to outcomes of patients with TNBC seen at a state charity hospital system. Methods: This retrospective review identified 194 pts with TNBC diagnosed between 1993-2011 at LSUHSC-Shreveport, a state charity hospital. TNBC was defined as ER/PR both <1% and HER2neu not overexpressed by FISH analysis. The patient’s race, age at diagnosis, stage at diagnosis, treatment, relapse free survival (RFS), overall survival and survival following confirmed metastatic disease were analyzed. Results: There was no statistical difference in frequency of stage between groups. Although not statistically significant, there was a trend to worse RFS in AA and in young pts of both races. Younger age at diagnosis did have an inferior median survival as compared to older pts regardless of race or stage (p=0.0476). There was no difference in median survival following confirmation of metastatic disease between races (p=0.3574) or between age groups (p=0.8548); (median survival = 31 mos, 2.56-204 mos). Conclusions: In a predominantly low income patient population the incidence of TNBC was higher in the AA and in the young (age ≤ 50) as expected. There was no difference in stage or frequency within the populations. However, outcomes appeared to be worse in the younger pts and in AA patients with higher recurrence rate. Survival following first recurrence was similar regardless of age and race. Further analysis of etiologies for racial and age disparities is needed. [Table: see text]

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3